Best countries

Best countries for stem-cell treatment, by condition (2026)

For each condition: sourced indicative prices, jurisdiction and travel context. Provider credentials and treatment suitability require separate verification.

Autism Spectrum Disorder

Evidence · regulatory status · indicative cost

Diabetes (Type 1 & 2)

Evidence · regulatory status · indicative cost

Multiple Sclerosis

Evidence · regulatory status · indicative cost

Parkinson's Disease

Evidence · regulatory status · indicative cost

Alzheimer's Disease

Evidence · regulatory status · indicative cost

Cerebral Palsy

Evidence · regulatory status · indicative cost

Spinal Muscular Atrophy

Evidence · regulatory status · indicative cost

Muscular Dystrophy

Evidence · regulatory status · indicative cost

Rheumatoid Arthritis

Evidence · regulatory status · indicative cost

Liver Cirrhosis

Evidence · regulatory status · indicative cost

Anemia

Evidence · regulatory status · indicative cost

Arterial Hypertension

Evidence · regulatory status · indicative cost

Erectile Dysfunction

Evidence · regulatory status · indicative cost

Male Infertility

Evidence · regulatory status · indicative cost

Primary Immunodeficiency

Evidence · regulatory status · indicative cost

Aesthetic & Anti-Ageing

Evidence · regulatory status · indicative cost

Intellectual Disability

Evidence · regulatory status · indicative cost

Knee Osteoarthritis

Evidence · regulatory status · indicative cost

Back Pain & Disc Degeneration

Evidence · regulatory status · indicative cost

Peripheral Neuropathy

Evidence · regulatory status · indicative cost

Stroke Recovery

Evidence · regulatory status · indicative cost

COPD & Lung Disease

Evidence · regulatory status · indicative cost

Crohn's & IBD

Evidence · regulatory status · indicative cost

Lupus (SLE)

Evidence · regulatory status · indicative cost

Chronic Kidney Disease

Evidence · regulatory status · indicative cost

Hair Loss & Restoration

Evidence · regulatory status · indicative cost

Long COVID

Evidence · regulatory status · indicative cost

Spinal Cord Injury

Evidence · regulatory status · indicative cost

Heart Failure & Cardiac Repair

Evidence · regulatory status · indicative cost

ALS (Motor Neurone Disease)

Evidence · regulatory status · indicative cost

Psoriasis

Evidence · regulatory status · indicative cost

Osteoporosis & Bone Health

Evidence · regulatory status · indicative cost

Tendon & Sports Injuries

Evidence · regulatory status · indicative cost

Chronic Wounds & Ulcers

Evidence · regulatory status · indicative cost

Macular Degeneration & Vision

Evidence · regulatory status · indicative cost

Fibromyalgia & Chronic Fatigue

Evidence · regulatory status · indicative cost

Hip Osteoarthritis

Evidence · regulatory status · indicative cost

Scleroderma (Systemic Sclerosis)

Evidence · regulatory status · indicative cost

Premature Ovarian Insufficiency

Evidence · regulatory status · indicative cost

Menopause & Hormonal Health

Evidence · regulatory status · indicative cost

Complex Regional Pain Syndrome

Evidence · regulatory status · indicative cost

Ulcerative Colitis

Evidence · regulatory status · indicative cost

Browse country comparisons

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information